Lithium Treatment Guidelines

Primary Indications

• The American Academy of Child and Adolescent Psychiatry recommends lithium as a first-line treatment for bipolar mania, along with valproate or carbamazepine, for individuals with bipolar I disorder 1, 2
• Lithium is recommended for maintenance treatment of bipolar disorder to reduce frequency and intensity of mood episodes, and should be offered for at least 2 years after the last episode 1

Specific Clinical Scenarios

Bipolar Mania

• Lithium should be initiated only in settings where close clinical and laboratory monitoring are available, and is typically used in combination with other medications such as valproate or carbamazepine 1, 2

Maintenance Treatment

• The American Academy of Child and Adolescent Psychiatry recommends that continuation of lithium beyond 2 years should preferably be decided by a mental health specialist 1

Age Considerations

• Lithium is FDA-approved for use in patients 12 years and older for both acute mania and maintenance therapy 3, 4

Monitoring Requirements

• Baseline laboratory assessment should include complete blood cell counts, thyroid function tests, urinalysis, blood urea nitrogen, creatinine, serum calcium levels, and pregnancy test in female adolescents, with regular monitoring of lithium levels, renal and thyroid function every 3-6 months 5

Important Considerations and Cautions

• Treatment with lithium should be initiated only where personnel and facilities for close clinical and laboratory monitoring are available, due to its narrow therapeutic window 1
• When discontinuing prophylactic therapy, it should be done gradually with close monitoring for relapse, as lithium withdrawal has been associated with increased risk of relapse, especially within 6 months of discontinuation 6

Lithium Monitoring Requirements for Augmentation Therapy

Target Therapeutic Ranges

• For augmentation purposes, blood levels of 0.2 to 0.6 mEq/L are generally adequate and are usually achieved with dosages of 150 to 300 mg per day, as recommended by the American Academy of Family Physicians 7
• The American Academy of Family Physicians suggests that some patients may respond at lower concentrations, but therapeutic monitoring is essential to guide optimization, with a target range of 0.2 to 0.6 mEq/L 7